Skip to Content

BEACH 1112 (Uroqid-acid methenamine mandelate 350 mg / sodium phosphate (monohydrate) 200 mg)

Pill with imprint BEACH 1112 is Yellow, Round and has been identified as Uroqid-acid methenamine mandelate 350 mg / sodium phosphate (monohydrate) 200 mg. It is supplied by Beach Pharmaceuticals.

and belongs to the drug class urinary anti-infectives. Risk cannot be ruled out during pregnancy. Methenamine/sodium acid phosphate methenamine mandelate 350 mg / sodium phosphate (monohydrate) 200 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for BEACH 1112

Uroqid-acid

Imprint:
BEACH 1112
Strength:
methenamine mandelate 350 mg / sodium phosphate (monohydrate) 200 mg
Color:
Yellow
Shape:
Round
Availability:
Prescription only
Drug Class:
Urinary anti-infectives
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Beach Pharmaceuticals
National Drug Code (NDC):
00486-1112

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide